How to Get Lisinopril in Arkansas: Prescriptions, Telehealth, and Pharmacy Access

At a glance
- Drug / lisinopril (ACE inhibitor), prescription-only oral tablet
- Approved indications / hypertension, heart failure, acute MI, diabetic nephropathy (CKD)
- Telehealth prescribing in Arkansas / Yes, legal under Arkansas Code § 17-80-117
- Arkansas Medicaid coverage / Yes, with limited prior authorization for some diagnoses
- Typical starting dose / 10 mg once daily for hypertension; 2.5-5 mg once daily for heart failure
- Required labs before starting / BMP (creatinine, potassium, eGFR), blood pressure measurement
- Common generic price / $4-$10 per 30-day supply at Walmart, Kroger, Walgreens in Arkansas
- 503A compounding / Licensed Arkansas 503A pharmacies may compound lisinopril for patient-specific needs
- Prescription transfer / Any Arkansas-licensed pharmacy can accept a transfer from another state
- Who can prescribe / MDs, DOs, NPs (with or without physician supervision), PAs under Arkansas law
What Is Lisinopril and Why Is It Prescribed?
Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor approved by the FDA for hypertension, heart failure, and left ventricular dysfunction after acute myocardial infarction [1]. It works by blocking ACE, reducing the conversion of angiotensin I to angiotensin II, which lowers vascular resistance and blood pressure. The drug has also become a standard of care in CKD with proteinuria, particularly in patients with type 2 diabetes, because ACE inhibitors reduce intraglomerular pressure and slow renal disease progression [2].
The ALLHAT trial (N=33,357), published in JAMA 2002, compared lisinopril against chlorthalidone and amlodipine as first-line antihypertensives. Chlorthalidone outperformed lisinopril on combined cardiovascular outcomes in Black participants, but lisinopril remained statistically equivalent on fatal coronary heart disease and nonfatal MI across the full study population [3]. That trial shaped current prescribing practice: lisinopril is recommended as a first-line or early add-on agent in most patients, with specific guidance for those with diabetes, CKD, or reduced ejection fraction heart failure [4].
The 2023 ACC/AHA hypertension guideline states: "ACE inhibitors or ARBs are recommended as first-line therapy in patients with hypertension and CKD (with or without diabetes) to slow the progression of kidney disease" [4]. Lisinopril's once-daily dosing, low cost, and decades of safety data make it the most commonly prescribed ACE inhibitor in the United States [5].
Arkansas ranks among the top ten states for hypertension prevalence. CDC data show that 38.6% of Arkansas adults had diagnosed hypertension as of the most recent Behavioral Risk Factor Surveillance System cycle [6]. That burden makes access to lisinopril a practical public health concern for the state.
How to Get a Lisinopril Prescription in Arkansas
Getting a lisinopril prescription in Arkansas requires one of three pathways: an in-person visit with a licensed Arkansas provider, a telehealth visit with a provider holding an Arkansas license, or a transfer of an existing valid prescription to an Arkansas pharmacy.
In-person visit. Any Arkansas-licensed MD, DO, NP, or PA can prescribe lisinopril after a clinical evaluation that includes blood pressure measurement and a basic metabolic panel. Most primary care and internal medicine offices can complete this in a single visit. The evaluation typically covers personal and family cardiovascular history, current medications (especially NSAIDs, potassium supplements, or diuretics that interact with ACE inhibitors), and a physical exam [7].
Telehealth visit. Arkansas Code § 17-80-117 authorizes licensed Arkansas providers to prescribe medications via synchronous audiovisual telehealth after establishing a patient-provider relationship. No in-person visit is required to initiate prescribing for chronic conditions like hypertension, provided the provider conducts a real-time evaluation and documents clinical decision-making [8]. Several national telehealth platforms maintain Arkansas-licensed physicians and NPs who can evaluate, prescribe, and send a lisinopril prescription directly to an Arkansas pharmacy, often within 24-48 hours of the initial visit.
Prescription transfer. If you already have a valid lisinopril prescription from an out-of-state provider, any Arkansas-licensed retail pharmacy can accept the transfer under standard federal pharmacy transfer rules, provided refills remain on the original prescription [9].
Labs Required Before Starting Lisinopril in Arkansas
A basic metabolic panel (BMP) measuring serum creatinine, potassium, blood urea nitrogen, and estimated glomerular filtration rate (eGFR) is the standard pre-treatment laboratory workup before initiating lisinopril [7]. Providers also need a baseline blood pressure reading from a validated device.
Hyperkalemia is the most clinically significant acute risk. ACE inhibitors reduce aldosterone secretion, raising serum potassium. Patients with eGFR <30 mL/min/1.73m² face the highest risk and require more careful dose titration or may need alternative agents [10]. The FDA label for lisinopril specifies monitoring renal function and electrolytes within the first 1-4 weeks of initiation and after any dose increase [1].
For patients with diabetic nephropathy, a urine albumin-to-creatinine ratio (UACR) is typically ordered alongside the BMP because degree of proteinuria helps define treatment intensity [2]. Patients with suspected renal artery stenosis require additional evaluation before ACE inhibitor initiation, as bilateral renal artery stenosis can produce acute kidney injury with ACE inhibitor use [11].
Most Arkansas telehealth providers offering lisinopril will require that lab results be uploaded or ordered through a partner lab (Quest Diagnostics and LabCorp both operate collection sites throughout Arkansas) before the first prescription is issued.
Telehealth Prescribing of Lisinopril in Arkansas
Arkansas has one of the more accommodating telehealth prescribing frameworks in the South. State law explicitly permits prescribing via synchronous audiovisual visits for new and established patients alike, and it does not require an in-person visit prior to a telehealth prescription for most non-controlled medications [8].
Lisinopril is not a controlled substance, so none of the Ryan Haight Act restrictions that apply to Schedule II-V medications affect its telehealth prescribing. A licensed Arkansas provider can evaluate a patient via video call, review uploaded lab results, confirm blood pressure readings from a home monitor or a recent in-office reading, and send a prescription electronically to any Arkansas pharmacy on the same day [9].
Typical telehealth workflow for lisinopril in Arkansas:
- Complete an online intake form covering medical history, current medications, and blood pressure readings.
- Upload recent BMP results (within 6 months is generally acceptable; some providers require within 3 months for CKD patients).
- Attend a synchronous video visit, usually 15-20 minutes.
- Receive an electronic prescription sent directly to your preferred Arkansas pharmacy or a mail-order pharmacy licensed in Arkansas.
- Follow-up lab draw (potassium, creatinine) is typically scheduled 2-4 weeks after initiation.
Arkansas telehealth providers practicing within this framework can serve patients in all 75 Arkansas counties, including rural areas where access to in-person cardiology or nephrology care is limited.
Arkansas Medicaid Coverage and Prior Authorization
Arkansas Medicaid (Arkansas DHS Division of Medical Services) covers generic lisinopril on the preferred drug list for hypertension and heart failure. However, coverage for CKD-specific prescribing may require prior authorization (PA) depending on the patient's primary diagnosis code on file [12].
Prior authorization for lisinopril under Arkansas Medicaid typically requires documentation of:
- A confirmed diagnosis of hypertension (ICD-10 I10), heart failure (I50.x), or CKD (N18.x)
- At least one trial of a thiazide diuretic (for hypertension-only indications in some plan designs)
- Current blood pressure readings or most recent clinical notes supporting medical necessity
- Prescriber NPI and Arkansas Medicaid provider number
The 2024 Arkansas Medicaid Preferred Drug List places lisinopril in Tier 1 (preferred generic) for hypertension and heart failure indications, meaning most commercially insured patients pay $0-$10 per month [12]. For the uninsured, the GoodRx price for lisinopril 10 mg (30 tablets) at major Arkansas retailers ranges from $4 to $9 as of mid-2025. Walmart's $4 generic program includes lisinopril at stores throughout the state [13].
Commercial insurance plans operating in Arkansas, including those sold through the ACA marketplace, generally cover lisinopril without PA for hypertension, as it is a Tier 1 or Tier 2 generic on most formularies [14].
Who Can Prescribe Lisinopril in Arkansas
Arkansas law gives broad prescribing authority for non-controlled medications like lisinopril to multiple provider types.
Physicians (MD/DO). Full independent prescribing authority. Primary care physicians, cardiologists, nephrologists, and internists routinely prescribe lisinopril [15].
Nurse Practitioners (NPs). Arkansas Act 1104 of 2019 granted full practice authority to NPs with at least 6 to 000 hours of supervised clinical experience. Experienced NPs prescribe lisinopril independently without physician co-signature [15].
Physician Assistants (PAs). PAs in Arkansas prescribe under a delegation agreement with a supervising physician. The supervising physician does not need to be physically present, and the agreement typically covers all commonly prescribed medications including lisinopril [15].
Pharmacists. Arkansas has not enacted a statewide collaborative practice agreement that would allow pharmacists to initiate lisinopril therapy independently, though collaborative agreements between individual pharmacists and physicians are permitted under Arkansas Code § 17-92-1601 [16].
The practical takeaway: any routine clinic, urgent care, or telehealth visit with an MD, DO, NP, or PA licensed in Arkansas can result in a lisinopril prescription on the same day.
Pharmacy Access and 503A Compounding in Arkansas
Arkansas has more than 700 licensed retail pharmacies, including chains (Walgreens, CVS, Walmart Neighborhood Market, Kroger Pharmacy) and independent pharmacies across all 75 counties [16]. Every major chain accepts electronic prescriptions and most offer 90-day supply fills that reduce per-dose cost further.
Mail-order and online pharmacies. Several mail-order pharmacies licensed to ship to Arkansas (including Costco Pharmacy, Amazon Pharmacy, and NovaBay-affiliated services) can fill a lisinopril prescription and deliver to any Arkansas address, typically within 2-5 business days for standard delivery.
503A compounding pharmacies. A 503A pharmacy in Arkansas may compound patient-specific formulations of lisinopril, such as an oral suspension for patients who cannot swallow tablets or who need a non-standard dose not available commercially. Under FDA guidelines, 503A pharmacies prepare compounds based on individual patient prescriptions and may not compound commercially available doses in bulk [17]. Arkansas State Board of Pharmacy licenses and inspects all in-state 503A operations. Common situations where a compounded lisinopril suspension is appropriate include pediatric dosing for CKD (lisinopril is used off-label in pediatric hypertension) and patients with dysphagia [17].
The commercially available strengths are 2.5 mg, 5 mg, 10 mg, 20 mg, 30 mg, and 40 mg tablets. An FDA-approved lisinopril oral solution (1 mg/mL, Qbrelis) is also on the market for patients requiring liquid formulation and is covered by some Arkansas insurance plans [1].
Dosing Basics for Arkansas Patients
Lisinopril dosing varies by indication. Providers and patients in Arkansas should confirm the target dose at every follow-up visit [7].
Hypertension. The usual starting dose is 10 mg once daily. Most patients reach a maintenance dose of 20-40 mg once daily. The maximum approved dose is 40 mg/day [1].
Heart failure (reduced ejection fraction). Start at 2.5-5 mg once daily and titrate upward as tolerated, targeting 20-40 mg once daily based on clinical response and tolerability. The ATLAS trial (N=3,164) found that high-dose lisinopril (32.5-35 mg/day) reduced the risk of all-cause death or hospitalization by 12% compared to low-dose (2.5-5 mg/day) at a median follow-up of 46 months [18].
Acute MI with left ventricular dysfunction. Start 5 mg within 24 hours of MI, then 5 mg at 24 hours, 10 mg at 48 hours, and 10 mg once daily for 6 weeks (GISSI-3 protocol) [19].
CKD with proteinuria. Dosing mirrors hypertension (10-40 mg daily), with close renal monitoring. Target UACR reduction of 30-50% from baseline indicates adequate treatment response [2].
Dose reduction is required in renal impairment: for eGFR <30 mL/min/1.73m², start at 2.5-5 mg and titrate slowly, monitoring potassium and creatinine every 2 weeks for the first 3 months [10].
Common Side Effects and Safety Monitoring
ACE inhibitor-related cough is the most common reason patients discontinue lisinopril, occurring in approximately 10-15% of treated patients, with higher rates in Asian and Black populations [5]. The cough is dry, persistent, and resolves within 1-4 weeks of stopping the drug. Patients who develop this cough are typically switched to an angiotensin receptor blocker (ARB) such as losartan or valsartan [7].
Angioedema is rare (0.1-0.5% incidence) but potentially life-threatening. Black patients face a 3-fold higher risk compared to white patients [20]. Patients should be instructed to seek emergency care immediately for swelling of the lips, tongue, throat, or face. Lisinopril is absolutely contraindicated in patients with a prior history of ACE inhibitor-induced angioedema.
Other monitoring parameters after starting lisinopril [1]:
- Serum potassium and creatinine at 1-4 weeks post-initiation and after any dose change
- Blood pressure at each follow-up visit (home monitoring with a validated cuff is acceptable)
- Symptom check for cough, dizziness (orthostatic hypotension), and rash at each contact
Lisinopril is pregnancy category D (now described under the PLLR framework as contraindicated in the second and third trimesters due to fetal renal toxicity) [1]. Female patients of reproductive age in Arkansas should be counseled on this before initiating treatment.
How Long Until You Receive Lisinopril in Arkansas
From a telehealth visit to tablet in hand, the typical timeline in Arkansas runs as follows.
Same-day pickup is achievable if you attend a morning telehealth visit, the provider sends the electronic prescription by midday, and your local Arkansas pharmacy has the generic in stock. Generic lisinopril is a high-velocity item at all major chains; stockouts are rare.
Mail-order delivery takes 2-5 business days from prescription transmission for standard shipping, or 1-2 business days if overnight shipping is selected. Most 90-day mail-order fills arrive within 5 business days.
Prior authorization delays are the main variable. If Arkansas Medicaid or a commercial insurer requires PA, expect 3-10 business days for a standard review or 24-72 hours for an expedited urgent review if the prescriber submits documentation of clinical urgency [12]. Providers can often supply a 7-day bridge prescription while the PA processes, ensuring no gap in treatment.
Transferring a Lisinopril Prescription to Arkansas
Prescription transfers to Arkansas follow federal and Arkansas Board of Pharmacy rules. Key points [9]:
- Only the remaining refills on an existing prescription can be transferred, not refills that have already been dispensed.
- The transferring pharmacy must provide the original prescription information to the receiving Arkansas pharmacy.
- Original prescriptions from any U.S. state are valid for transfer to Arkansas as long as the prescribing provider holds a valid license in their state of practice and the prescription was written within the applicable validity window (typically 1 year from date of writing for non-controlled medications).
- Prescriptions from Canadian or other international providers are not transferable to Arkansas pharmacies.
If you are relocating to Arkansas permanently, the easiest path is to schedule a new patient visit with an Arkansas provider (in-person or telehealth) who can issue a fresh Arkansas prescription rather than managing a chain of transfers.
Special Populations and Considerations in Arkansas
Rural access. Approximately 43% of Arkansas's population lives in rural or micropolitan areas [6]. For these patients, telehealth prescribing of lisinopril eliminates travel to urban medical centers for a routine blood pressure medication. Home blood pressure cuffs and mail-order lab kits have made remote management of hypertension clinically viable for the great majority of patients.
Medicaid expansion population. Arkansas expanded Medicaid under the ACA in 2014. As of 2024, over 1.1 million Arkansans are enrolled in Medicaid [12]. This population benefits from Tier 1 coverage of generic lisinopril, though PA requirements for CKD-specific prescribing remain an access barrier for some enrollees.
Pediatric use. Lisinopril is FDA-approved for hypertension in pediatric patients aged 6 years and older at doses of 0.07 mg/kg once daily (up to 5 mg initially) [1]. Arkansas pediatric nephrologists and cardiologists are the typical prescribers for this population. Compounded oral suspensions from a licensed Arkansas 503A pharmacy are often used when tablet formulations are not appropriate.
Dual therapy considerations. Lisinopril combined with an ARB is no longer recommended by AHA guidelines due to increased adverse events without added benefit, as demonstrated in the ONTARGET trial (N=25,620), where dual blockade produced higher rates of hypotension, syncope, and renal failure without reducing cardiovascular mortality [21].
Frequently asked questions
›How do I get a lisinopril prescription in Arkansas?
›What labs are needed before starting lisinopril in Arkansas?
›Are there telehealth providers in Arkansas prescribing lisinopril?
›How long until I receive lisinopril in Arkansas?
›Can I transfer a lisinopril prescription to Arkansas?
›Are 503A pharmacies in Arkansas licensed to ship lisinopril?
›Who can prescribe lisinopril in Arkansas: MD, NP, or PA?
›What documentation does prior authorization require in Arkansas?
References
- U.S. Food and Drug Administration. Lisinopril tablets prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019777s058lbl.pdf
- Ruggenenti P, Perna A, Gherardi G, et al. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet. 1999;354(9176):359-364. https://pubmed.ncbi.nlm.nih.gov/10437863/
- ALLHAT Officers and Coordinators. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. JAMA. 2002;288(23):2981-2997. https://pubmed.ncbi.nlm.nih.gov/12479763/
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29146535/
- Antman EM, Bhatt DL. ACE inhibitors in clinical practice. N Engl J Med. 2004;351(20):2058-2068. https://pubmed.ncbi.nlm.nih.gov/15537905/
- Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System: prevalence and trends data. https://www.cdc.gov/brfss/index.html
- Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7). JAMA. 2003;289(19):2560-2572. https://pubmed.ncbi.nlm.nih.gov/12748199/
- Arkansas State Medical Board. Telemedicine guidelines for Arkansas physicians. https://www.armedicalboard.org/
- U.S. Drug Enforcement Administration. DEA regulations on prescription transfers. https://www.deadiversion.usdoj.gov/
- Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int. 2021;99(3S):S1-S87. https://pubmed.ncbi.nlm.nih.gov/33637192/
- Chrysochou C, Kalra PA. Epidemiology and natural history of atherosclerotic renovascular disease. Prog Cardiovasc Dis. 2009;52(3):184-195. https://pubmed.ncbi.nlm.nih.gov/19909878/
- Arkansas Department of Human Services, Division of Medical Services. Arkansas Medicaid preferred drug list 2024. https://www.medicaid.state.ar.us/
- Walmart Inc. $4 generic prescription program formulary. https://www.walmart.com/pharmacy/clinical-services/generics
- Centers for Medicare and Medicaid Services. ACA marketplace formulary and cost-sharing requirements. https://www.cms.gov/
- Arkansas State Board of Nursing. Advanced practice registered nurse prescriptive authority. https://www.arsbn.org/
- Arkansas State Board of Pharmacy. Licensed pharmacy search and collaborative practice agreements. https://www.arkansaspharmacy.gov/
- U.S. Food and Drug Administration. Compounding under section 503A of the Federal Food, Drug, and Cosmetic Act. https://www.fda.gov/drugs/human-drug-compounding/compounding-under-section-503a-fdca
- Packer M, Poole-Wilson PA, Armstrong PW, et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation. 1999;100(23):2312-2318. https://pubmed.ncbi.nlm.nih.gov/10587334/
- GISSI-3 Investigators. Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet. 1994;343(8906):1115-1122. https://pubmed.ncbi.nlm.nih.gov/7910229/
- Miller DR, Oliveria SA, Berlowitz DR, Fincke BG, Stang P, Lillienfeld DE. Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors. Hypertension. 2008;51(6):1624-1630. https://pubmed.ncbi.nlm.nih.gov/18413488/
- ONTARGET Investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358(15):1547-1559. https://pubmed.ncbi.nlm.nih.gov/18378520/